MEM 0.00% 0.5¢ memphasys limited.

Ann: Suspension from Official Quotation-NSP.AX, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 413 Posts.
    lightbulb Created with Sketch. 1
    I'm very keen to know how much we'll get for our stake in PrIME?
    Speaking at AGM last year, our Chair said:
    "PIME has still not passed cGMP accreditation and it has not provided a date for its next attempt. However, it has received a cash injection of SGD$8.8 million by the Class A shareholders despite not hitting its next funding milestone. PrIME has now received nearly SGD$20 million in external funding, which NuSep could not have provided, but we do not have oversight of how that funding is being applied so we are not in a position to share that with you today. The plasma separation machine that PrIME is using for its cGMP accreditation is rented by NuSep to PrIME. The machine is sufficient to provide a “proof of concept” volume of processed plasma but is not big enough to produce a commercial volume of plasma products. The next step for PrIME, after receiving cGMP accreditation, will be to scale up the operation. NuSep currently has 55.1% of PrIME but there is a dispute about the quantum of the interest on the recent cash injection which will vary this position. We have concerns about the lack of transparency in the reporting of PrIME’s activities, especially in budgeting and scheduling and in their current commercial dealings with large players in the plasma fractionation business. We have expressed our concerns and have left our options open to take further action if our concerns are not properly dealt with. To date they have not been dealt with in a satisfactory manner."

    and the year before she noted:
    "We expect the present book value of $3.8m of the PrIME asset on NuSep’s balance sheet will substantially increase over the time, which will have a positive impact on NuSep’s net asset position. Also, as we grow the SpermSep business, its value should also improve and add to a more positive net asset position."
    Let's hope we get the positive balance sheet impact that was predicted when the sale goes through, although I still haven't been able to find anything on PrIME's website or the net to indicate that they have received cGMP accreditation. Does anyone know the current state of play?
    GLTA
    Kind regards,
 
watchlist Created with Sketch. Add MEM (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.000(0.00%)
Mkt cap ! $13.00M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $25.15K 5.030M

Buyers (Bids)

No. Vol. Price($)
15 18776263 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 10551662 4
View Market Depth
Last trade - 10.32am 08/11/2024 (20 minute delay) ?
MEM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.